5-bromo-6-hydroxy-3,4-dihydro-1(2H)-naphthalenone | 107318-16-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 英文名称: 5-bromo-6-hydroxy-3,4-dihydro-1(2H)-naphthalenone
• 英文别名: 5-Bromo-6-hydroxy-2,3,4-trihydronapthalen-1-one；5-bromo-6-hydroxy-α-tetralone；5-Bromo-6-hydroxy-1-tetralone；5-bromo-6-hydroxy-3,4-dihydro-2H-naphthalen-1-one
• CAS: 107318-16-1
• 化学式: C₁₀H₉BrO₂
• 分子量: 241.084
• InChiKey: ZNRMQXMUKLXGDT-UHFFFAOYSA-N

物化性质

• 沸点：
  380.7±42.0 °C(Predicted)
• 密度：
  1.635±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-bromo-6-hydroxy-3,4-dihydro-1(2H)-naphthalenone 在 ammonium hydroxide 、 sodium hydroxide 、 N-溴代丁二酰亚胺(NBS) 、 水 、 N,N-二乙基苯胺 作用下， 以 1,4-二氧六环 、 乙醇 、 二甲基亚砜 为溶剂， 生成 (3R,4S)-4-amino-10-bromo-3-hydroxy-2,2-dimethyl-4,7,8,9-tetrahydro-3H-benzo[g]chromen-6-one
  参考文献：
  名称：

  Conformational preference of the 6-acetyl group in novel anticonvulsant trans 4S-benzamido-benzo[b]pyran-3R-ols

  摘要：

  Conformationally restricted ketones derived from the novel anticonvulsant 4S (4-fluorobenzoylamino)benzopyran SB-204269 1 have revealed a preferred ''in plane'' conformation which is essential for optimal potency at a unique receptor site. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(97)00264-3
• 作为产物：
  描述：

  6-羟基-1-四氢萘酮 在 溴 、 sodium acetate 、 sodium hydride 、 三氟乙酸 作用下， 以 二氯甲烷 、 溶剂黄146 、 N,N-二甲基甲酰胺 为溶剂， 生成 5-bromo-6-hydroxy-3,4-dihydro-1(2H)-naphthalenone
  参考文献：
  名称：

  Conformational preference of the 6-acetyl group in novel anticonvulsant trans 4S-benzamido-benzo[b]pyran-3R-ols

  摘要：

  Conformationally restricted ketones derived from the novel anticonvulsant 4S (4-fluorobenzoylamino)benzopyran SB-204269 1 have revealed a preferred ''in plane'' conformation which is essential for optimal potency at a unique receptor site. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(97)00264-3

文献信息

• 5- substituted tetralones as inhibitors of ras farnesyl trransferase
  申请人：——

  公开号：US20040044057A1

  公开（公告）日：2004-03-04

  The present invention provides novel 5-substituted tetralones of Formulas (I), (II), (III) and (IV) and pharmaceutically acceptable salts, esters, amides, and prodrugs thereof, which are useful for treating and preventing uncontrolled or abnormal proliferation of tissues, such as cancer, atherosclerosis, restenosis, and psoriasis. Specifically, the present invention relates to compounds that inhibit the farnesyl transferase enzyme. 1

  本发明提供了式(I)、(II)、(III)和(IV)的新型5-取代四酮及其药学上可接受的盐、酯、酰胺和前药，用于治疗和预防组织的不受控制或异常增殖，如癌症、动脉粥样硬化、再狭窄和银屑病。具体而言，本发明涉及抑制法尼基转移酶酶的化合物。
• Tetrahydro-6,7-dimethoxy-1H-benz[e]isoinodolines useful in the treatment
  申请人：Abbott Laboratories

  公开号：US04618683A1

  公开（公告）日：1986-10-21

  Disclosed herein are tetrahydro-benzo[e]isoindolines represented by the formula ##STR1## wherein R, R.sub.1 and R.sub.2 are independently selected from hydrogen, loweralkyl of 1 to 4 carbon atoms, hydroxy, loweralkoxy of 1 to 3 carbon atoms, allyloxy, benzyloxy, benzoyloxy, thiomethyl, halo, ##STR2## wherein t is 0 or 1, n is 0 to 5 and R.sub.11 and R.sub.14 are independently selected from hydrogen, halo, hydroxy, loweralkyl of 1 to 4 carbon atoms, loweralkoxy of 1 to 3 carbon atoms or amino; or R and R.sub.1, or R.sub.1 and R.sub.2 can be taken together to form a methylenedioxy or ethylenedioxy bridge; with the proviso that at least one of R, R.sub.1 or R.sub.2 must be other than hydrogen and the proviso that two of R, R.sub.1, or R.sub.2 must be other than methoxy in the 7 and 8 positions when the remaining one of R, R.sub.1 or R.sub.2 is hydrogen; and R.sub.3 is hydrogen, loweralkyl of 1 to 4 carbon atoms, halo-substituted loweralkyl of 1 to 4 carbon atoms, amino-substituted loweralkyl of 1 to 4 carbon atoms, amino-substituted arylalkyl, allyl, thioloweralkyl, loweralkanol, or ##STR3## wherein R.sub.12 and R.sub.13 are independently selected from hydrogen, hydroxy, amino, loweralkoxy of 1 to 3 carbon atoms and s is 1 to 3; or ##STR4## wherein m is 0, 1 or 2, p is 0 or 1, R.sub.7 is hydrogen or loweralkyl of 1 to 4 carbon atoms and R.sub.8 and R.sub.9 are independently selected from hydrogen, hydroxy, methoxy, loweralkyl of 1 to 4 carbon atoms, or halo, or R.sub.8 and R.sub.9 can be taken together to form a methylenedioxy or ethylenedioxy bridge; or 1,4-benzodioxan of the formula ##STR5## wherein q is 1, 2 or 3, and R.sub.10 is hydrogen, methoxy, amino, or halo; and the pharmaceutically acceptable salts thereof.

  本公开涉及的是由以下式表示的四氢-苯并[e]异喹啉：其中R、R.sub.1和R.sub.2分别选自氢、1至4个碳原子的低碳烷基、羟基、1至3个碳原子的低碳氧烷基、烯丙氧基、苄氧基、苯甲酰氧基、硫甲基、卤素、t为0或1、n为0至5、R.sub.11和R.sub.14分别选自氢、卤素、羟基、1至4个碳原子的低碳烷基、1至3个碳原子的低碳氧烷基或氨基；或R和R.sub.1，或R.sub.1和R.sub.2可以结合形成亚甲二氧桥或乙烯二氧桥；但R、R.sub.1或R.sub.2中至少有一个必须不是氢，且当R、R.sub.1或R.sub.2中的另外一个是氢时，R、R.sub.1或R.sub.2中的两个必须不是7和8位置的甲氧基；R.sub.3是氢、1至4个碳原子的低碳烷基、1至4个碳原子的卤素取代的低碳烷基、1至4个碳原子的氨基取代的低碳烷基、氨基取代的芳基烷基、烯丙基、硫代低碳烷基、低碳醇、或其中R.sub.12和R.sub.13分别选自氢、羟基、氨基、1至3个碳原子的低碳氧烷基，s为1至3；或m为0、1或2、p为0或1、R.sub.7为氢或1至4个碳原子的低碳烷基，R.sub.8和R.sub.9分别选自氢、羟基、甲氧基、1至4个碳原子的低碳烷基或卤素，或R.sub.8和R.sub.9可以结合形成亚甲二氧桥或乙烯二氧桥；或以下式的1,4-苯并二氧杂环己烷：其中q为1、2或3，R.sub.10为氢、甲氧基、氨基或卤素；以及其药学上可接受的盐。
• Ortho-aminomethylphenol compounds
  申请人：Yoshitomi Pharmaceutical Industries, Ltd.

  公开号：US04709095A1

  公开（公告）日：1987-11-24

  Ortho-aminomethylphenol compounds of the formula: ##STR1## wherein X is hydrogen or halogen, R is hydrogen or alkyl having 1 to 4 carbon atoms and A is alkyl having 1 to 4 carbon atoms, phenyl, benzyl or a bivalent radical selected from --(CH.sub.2).sub.3 -- and --O(CH.sub.2).sub.2 -- and joined together with the 3 or 5 position of the benzene nucleus to form a bicycle, or pharmaceutically acceptable salts thereof, a method of preparing said compounds and a pharmaceutical composition containing said compounds, are disclosed. Such compounds exhibit antiinflammatory, analgesic, diuretic and antihypertensive activities, so they are useful in the treatment for diseases caused by inflammation, edema or hypertension.

  本发明揭示了化合物的配方为：##STR1## 其中X是氢或卤素，R是氢或具有1至4个碳原子的烷基，A是具有1至4个碳原子的烷基、苯基、苄基或从--（CH.sub.2）.sub.3--和--O（CH.sub.2）.sub.2--中选择的二价基团，并与苯环的3或5位置结合形成一个自行车，或其药学上可接受的盐，揭示了制备该化合物的方法和含有该化合物的制药组合物。这些化合物表现出抗炎、镇痛、利尿和降压活性，因此它们在治疗由炎症、水肿或高血压引起的疾病方面是有用的。
• Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2
  申请人：Pharmacia Corporation

  公开号：US20040127492A1

  公开（公告）日：2004-07-01

  Cyclic pyrazole compounds are described which inhibit mitogen activated protein kinase-activated protein kinase-2 (MK-2). Methods of making such compounds are described, as well as a method of using them for the inhibition of MK-2 in a subject in need of such inhibition, where the method involves administering to the subject an MK-2 inhibiting compound of the present invention. Pharmaceutical compositions and kits which contain the present MK-2 inhibiting compounds are also described.

  本发明涉及一种环状吡唑化合物，其能够抑制丝裂原活化蛋白激酶激活蛋白激酶-2（MK-2）。本发明还描述了制备这种化合物的方法，以及一种使用它们来抑制需要这种抑制的受体的方法，其中该方法涉及向受体中注射本发明的MK-2抑制化合物。本发明还描述了包含本MK-2抑制化合物的药物组合物和工具箱。
• O-AMINOMETHYLPHENOL COMPOUNDS
  申请人：Yoshitomi Pharmaceutical Industries, Ltd.

  公开号：EP0191108A1

  公开（公告）日：1986-08-20

  o-Aminomethylphenol compounds represented by general formula (I), (wherein X represents hydrogen or halogen, R represents hydrogen or C1-4 alkyl, A represents C1-4 alkyl, phenyl, benzyl or a bifunctional chain of -(CH2)3-or -O(CH2)2-bound to position 3 or 5 of the benzene nucleus to form a bicyclic system) or pharmaceutically acceptable salts thereof, a process for their preparation, and a pharmaceutical composition containing them. The compounds have antiinflammatory, analgesic, diuretic, and hypotensive effects, and are useful for treating diseases due to inflammation, edema, hypertension, etc.

  o-Aminomethylphenol compounds represented by general formula (I), (wherein X represents hydrogen or halogen, R represents hydrogen or C1-4 alkyl, A represents C1-4 alkyl, phenyl, benzyl or a bifunctional chain of -(CH2)3-or -O(CH2)2-bound to position 3 or 5 of the benzene nucleus to form a bicyclic system) or pharmaceutically acceptable salts of thereof, a process for their preparation, and a pharmaceutical composition containing them. 这些化合物具有抗炎、镇痛、利尿和降压作用，可用于治疗炎症、水肿、高血压等疾病。